Related Experiment Video
Updated: Mar 31, 2026
10:45
Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts
Published on: March 12, 2020
17.4K
Microarray profiling to analyse adult cardiac fibroblast identity
Milena B Furtado1, Hieu T Nim2, Jodee A Gould3
1Australian Regenerative Medicine Institute, Monash University, VIC 3800, Australia.
Genomics Data
|October 21, 2015
Summary
Cardiac fibroblasts possess unique molecular signatures, suggesting their potential for regenerative medicine. This study details their gene expression profiling and analysis, offering insights into heart failure therapies.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cell Biology
Background:
- Heart failure is a leading global cause of death with limited therapeutic options.
- Fibrosis, driven by fibroblast activity, is a key pathological feature of heart failure.
- Cardiac fibroblasts have been historically underestimated but play active roles in tissue homeostasis and disease.
Purpose of the Study:
- To investigate the molecular identity of cardiac fibroblasts.
- To explore the potential of cardiac fibroblasts in stem cell replacement therapies.
- To provide reproducible methods for cardiac fibroblast gene expression analysis.
Main Methods:
- Gene expression profiling of cardiac fibroblasts.
- Analysis of cell surface markers.
- Data deposition in Gene Expression Omnibus (GEO) under accession number GSE50531.
- Provision of R code for data analysis.
Main Results:
- Cardiac fibroblasts exhibit a unique molecular identity with cardiogenic transcription factors.
- Approximately 90% of cardiac and tail fibroblasts share cell surface markers with mesenchymal stem cells (MSCs).
- Findings suggest cardiac fibroblasts may be suitable for stem cell replacement therapies.
Conclusions:
- Cardiac fibroblasts have a distinct molecular profile with implications for regenerative medicine.
- The shared MSC-like signature suggests a potential identity link between fibroblasts and MSCs.
- This research provides a foundation for developing novel heart failure treatments using cardiac fibroblasts.
